title: In vivo assessment of gene delivery to keratinocytes by lentiviral vectors.
abstract: For skin gene therapy, introduction of a desired gene into keratinocyte progenitor or stem cells could overcome the problem of achieving persistent gene expression in a significant percentage of keratinocytes. Although keratinocyte stem cells have not yet been completely characterized and purified for gene targeting purposes, lentiviral vectors may be superior to retroviral vectors at gene introduction into these stem cells, which are believed to divide and cycle slowly. Our initial in vitro studies demonstrate that lentiviral vectors are able to efficiently transduce nondividing keratinocytes, unlike retroviral vectors, and do not require the lentiviral accessory genes for keratinocyte transduction. When lentiviral vectors expressing green fluorescent protein (GFP) were directly injected into the dermis of human skin grafted onto immunocompromised mice, transduction of dividing basal and nondividing suprabasal keratinocytes could be demonstrated, which was not the case when control retroviral vectors were used. However, flow cytometry analysis demonstrated low transduction efficiency, and histological analysis at later time points provided no evidence for progenitor cell targeting. In an alternative in vivo method, human keratinocytes were transduced in tissue culture (ex vivo) with either lentiviral or retroviral vectors and grafted as skin equivalents onto immunocompromised mice. GFP expression was analyzed in these human skin grafts after several cycles of epidermal turnover, and both the lentiviral and retroviral vector-transduced grafts had similar percentages of GFP-expressing keratinocytes. This ex vivo grafting study provides a good in vivo assessment of gene introduction into progenitor cells and suggests that lentiviral vectors are not necessarily superior to retroviral vectors at introducing genes into keratinocyte progenitor cells during in vitro culture.
authors.affiliation: Dermatology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
authors.forename: Ulrich
authors.initials: U
authors.lastname: Kuhn
authors.forename: Atsushi
authors.initials: A
authors.lastname: Terunuma
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Pfutzner
authors.forename: Ruth Ann
authors.initials: RA
authors.lastname: Foster
authors.forename: Jonathan C
authors.initials: JC
authors.lastname: Vogel
mesh_terms: D000818:Animals; D002455:Cell Division; D002461:Cell Line, Transformed; D002478:Cells, Cultured; D018014:Gene Transfer Techniques; D005822:Genetic Vectors / Q000235:genetics / Q000502:physiology*; D006801:Humans; D015603:Keratinocytes / Q000166:cytology*; D016086:Lentivirus / Q000235:genetics / Q000502:physiology*; D008562:Membrane Glycoproteins; D051379:Mice; D008819:Mice, Nude; D012190:Retroviridae / Q000235:genetics / Q000502:physiology; D012867:Skin / Q000378:metabolism; D013234:Stem Cells / Q000166:cytology; D014161:Transduction, Genetic; D014759:Viral Envelope Proteins / Q000235:genetics
chemical_list: C028391:G protein, vesicular stomatitis virus; D008562:Membrane Glycoproteins; D014759:Viral Envelope Proteins